Teva’s Suggested opioid settlement May cost drugmaker pennies on the dollar

Teva's proposed opioid settlement May cost drugmaker pennies 3NEW YORK/BOSTON (Reuters) – Teva Pharmaceutical Industries Ltd’s proposed $23 billion drug giveaway to settle tens of thousands of U.S. opioid lawsuits will likely cost the organization a portion of that figure because of the way it has valued those medicines, according to a Reuters review of pricing data and business analysts. When Teva declared the value of this…
News story posted on 2019-10-23T19:08:00.0000000Z